Future prospects for primary hormone therapy in localized and locally advanced prostate cancer

Fernand Labrie, Mark S. Soloway, Hideyuki Akaza, Yoshihiko Hirao

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The authors consider current and future prospects for primary hormone therapy in localized and locally advanced prostate cancer by comparing this form of treatment (hormone monotherapy) with neoadjuvant radiation therapy and radical prostatectomy. Neoadjuvant hormone therapy prior to radiation therapy has been proven effective in recent years, and currently the United States is showing a year-by-year increase in the use of androgen blocking agents during the early stage of prostate cancer. A survey of recent research findings, clearly showed that, for patients with localized prostate cancer, there is no significant difference in survival rate between hormone monotherapy and radical prostatectomy. In the future we can expect to see an increase in available treatment options for localized and locally advanced prostate cancer, with the optimal therapy for each individual patient to be selected by the attending physician in discussion with the patient.

Original languageEnglish
Pages (from-to)771-777
Number of pages7
JournalActa Urologica Japonica
Volume49
Issue number12
StatePublished - Dec 1 2003
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Hormones
Neoadjuvant Therapy
Prostatectomy
Radiotherapy
Therapeutics
Androgens
Survival Rate
Physicians
Research

Keywords

  • Androgen blockade
  • Hormone therapy
  • Neoadjuvant therapy
  • Organ confined
  • Radical prostatectomy

ASJC Scopus subject areas

  • Urology

Cite this

Labrie, F., Soloway, M. S., Akaza, H., & Hirao, Y. (2003). Future prospects for primary hormone therapy in localized and locally advanced prostate cancer. Acta Urologica Japonica, 49(12), 771-777.

Future prospects for primary hormone therapy in localized and locally advanced prostate cancer. / Labrie, Fernand; Soloway, Mark S.; Akaza, Hideyuki; Hirao, Yoshihiko.

In: Acta Urologica Japonica, Vol. 49, No. 12, 01.12.2003, p. 771-777.

Research output: Contribution to journalArticle

Labrie, F, Soloway, MS, Akaza, H & Hirao, Y 2003, 'Future prospects for primary hormone therapy in localized and locally advanced prostate cancer', Acta Urologica Japonica, vol. 49, no. 12, pp. 771-777.
Labrie, Fernand ; Soloway, Mark S. ; Akaza, Hideyuki ; Hirao, Yoshihiko. / Future prospects for primary hormone therapy in localized and locally advanced prostate cancer. In: Acta Urologica Japonica. 2003 ; Vol. 49, No. 12. pp. 771-777.
@article{0f5b5a2241004880bb64a58e416760d9,
title = "Future prospects for primary hormone therapy in localized and locally advanced prostate cancer",
abstract = "The authors consider current and future prospects for primary hormone therapy in localized and locally advanced prostate cancer by comparing this form of treatment (hormone monotherapy) with neoadjuvant radiation therapy and radical prostatectomy. Neoadjuvant hormone therapy prior to radiation therapy has been proven effective in recent years, and currently the United States is showing a year-by-year increase in the use of androgen blocking agents during the early stage of prostate cancer. A survey of recent research findings, clearly showed that, for patients with localized prostate cancer, there is no significant difference in survival rate between hormone monotherapy and radical prostatectomy. In the future we can expect to see an increase in available treatment options for localized and locally advanced prostate cancer, with the optimal therapy for each individual patient to be selected by the attending physician in discussion with the patient.",
keywords = "Androgen blockade, Hormone therapy, Neoadjuvant therapy, Organ confined, Radical prostatectomy",
author = "Fernand Labrie and Soloway, {Mark S.} and Hideyuki Akaza and Yoshihiko Hirao",
year = "2003",
month = "12",
day = "1",
language = "English",
volume = "49",
pages = "771--777",
journal = "Acta Urologica Japonica",
issn = "0018-1994",
publisher = "Editorial Board of Acta Urologica Japonica",
number = "12",

}

TY - JOUR

T1 - Future prospects for primary hormone therapy in localized and locally advanced prostate cancer

AU - Labrie, Fernand

AU - Soloway, Mark S.

AU - Akaza, Hideyuki

AU - Hirao, Yoshihiko

PY - 2003/12/1

Y1 - 2003/12/1

N2 - The authors consider current and future prospects for primary hormone therapy in localized and locally advanced prostate cancer by comparing this form of treatment (hormone monotherapy) with neoadjuvant radiation therapy and radical prostatectomy. Neoadjuvant hormone therapy prior to radiation therapy has been proven effective in recent years, and currently the United States is showing a year-by-year increase in the use of androgen blocking agents during the early stage of prostate cancer. A survey of recent research findings, clearly showed that, for patients with localized prostate cancer, there is no significant difference in survival rate between hormone monotherapy and radical prostatectomy. In the future we can expect to see an increase in available treatment options for localized and locally advanced prostate cancer, with the optimal therapy for each individual patient to be selected by the attending physician in discussion with the patient.

AB - The authors consider current and future prospects for primary hormone therapy in localized and locally advanced prostate cancer by comparing this form of treatment (hormone monotherapy) with neoadjuvant radiation therapy and radical prostatectomy. Neoadjuvant hormone therapy prior to radiation therapy has been proven effective in recent years, and currently the United States is showing a year-by-year increase in the use of androgen blocking agents during the early stage of prostate cancer. A survey of recent research findings, clearly showed that, for patients with localized prostate cancer, there is no significant difference in survival rate between hormone monotherapy and radical prostatectomy. In the future we can expect to see an increase in available treatment options for localized and locally advanced prostate cancer, with the optimal therapy for each individual patient to be selected by the attending physician in discussion with the patient.

KW - Androgen blockade

KW - Hormone therapy

KW - Neoadjuvant therapy

KW - Organ confined

KW - Radical prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=1042302815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1042302815&partnerID=8YFLogxK

M3 - Article

C2 - 14978964

AN - SCOPUS:1042302815

VL - 49

SP - 771

EP - 777

JO - Acta Urologica Japonica

JF - Acta Urologica Japonica

SN - 0018-1994

IS - 12

ER -